RECIST best response summary
| Best RECIST response | |
| Confirmed CR | 1 (6) |
| Confirmed PR | 3 (19) |
| Unconfirmed PR | 1 (6) |
| Clinical benefit (stable disease for 6 months+) | 2 (12) |
| Progression | 7 (44) |
| Not assessed* | 2 (12) |
N (%) reported.
*Two patients did not have tumor measurements available and were not assessable due to stopping protocol therapy due to adverse events before first scan (n=1) or death before first assessment time point (n=1).
CR, complete response; PR, partial response.